Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease

E-ISSN： 1875-6115|12|2|118-121

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.12, Iss.2, 2012-06, pp. : 118-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High Density Lipoprotein Administration: A New Therapeutic Modality for the Treatment of Cardiovascular Diseases

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 4, 2005-08 ,pp. : 321-333

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 527-532

Bentham Science Publishers

Access to resources Recommend Favorite

A beta oligomerization A Therapeutic Target for Alzheimers Disease

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 1, Iss. 1, 2001-05 ,pp. : 25-38

Bentham Science Publishers

Access to resources Recommend Favorite

Common Therapeutic Strategies in the Management of Sexual Dysfunction and Cardiovascular Disease

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 2, 2005-04 ,pp. : 185-195

Bentham Science Publishers

Access to resources Recommend Favorite

Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 481-488

Bentham Science Publishers

Access to resources Recommend Favorite